Meet a $200K Challenge Finalist: MicroBioMed Corporation

MicroBioMed is a 2020 M2D2 $200K Challenge Finalist.

In light of recent unprecedented events surrounding the COVID-19 outbreak, the decision has been made to host the 2020 $200K Challenge virtually this fall with free registration. The PitchOff is scheduled for Thursday, September 17th from 5:00- 8:00 pm, and the Award Celebration is set for Thursday, October 1st at 5:00 pm.

As the newly rescheduled virtual events approach, we want to shine the spotlight on another unique $200K Challenge finalist. MicroBioMed is developing an operator-independent measurement device to quantitatively study vaginal wall skin properties. We talked to William Gardetto, COO of MicroBioMed to learn more about what led them to the $200K Challenge.

Continue reading

Meet a 2020 $200K Challenge Finalist: Hyalex Orthopaedics

Hyalex Orthopaedics is a 2020 M2D2 $200K Challenge Finalist.

Our finalists for this year’s $200K Challenge are experiencing our traditional event in a very unique way. The event will be held virtually, with the PitchOff taking place on September 17th and the Award Celebration on October 1st, and will be completely free with registration. While this year’s event looks different, we still want to bring attention to each of our unique finalists and their innovations.

Continue reading

LaunchPad Medical Initiates its First European Clinical Study

The summer of 2020 continues to bring forth exciting news on our resident companies. LaunchPad Medical has announced that it received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study. The goal is to examine the safety and efficacy of Tetranite®, the company’s bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions.

Continue reading

Meet a 2020 $200K Challenge Finalist: Cx Therapeutics

Finalists for the 2020 M2D2 $200K Challenge have been announced.

Though this year’s $200K Challenge will take place virtually, this year’s finalists’ are still top of mind. The PitchOff will now be held on Zoom on September 17th from 5-8pm, as will the Award Celebration on October 1st at 5pm. Additionally, the $200K Challenge will be free with registration.

Recently, we caught up with Michael House, President of Cx Therapeutics. His titles include Principal Investigator, Mother Infant Research Institute and Associate Professor of Medicine at Tufts Medical Center.

Continue reading

Catching up with $200K Challenge Winner EnClear Therapies

EnClear Therapies was a 2019 $200K Challenge Winner.

In April of 2019, Newburyport, Massachusetts-based EnClear Therapies was named a winner in the 8th annual M2D2 $200K Challenge. Their innovation: a treatment device to stop progress of neurodegenerative diseases. The 2020 Challenge is coming up this fall, and because we’re always interested in the progress of past winners, we reached out to EnClear’s Vice President of R&D/Operations Kevin Kalish to get an update.

Continue reading

Meet a 2020 $200K Challenge Finalist: Profilagen

Although this year’s challenge will occur virtually, we want to keep the spotlight on this year’s Finalists. The PitchOff will now take place on September 17th from 5-8pm, with the Award Ceremony happening on October 1st at 5pm. Registration for the $200k Challenge will be free.

Profilagen is a start-up preclinical LLC bringing forward a technology to regenerate damaged cardiac muscle. We spoke with CEO Claudine Bruck about the inspiration behind Profilagen, and their story so far.

Continue reading